Alliance Imaging reports stellar 1996
Mobile imaging provider Alliance Imaging, of Orange, CA, turnedin strong revenue and net income numbers for 1996 (end-December).The company said that its debt restructuring is nearly complete,which will enable Alliance to accelerate its growth plan.For
Mobile imaging provider Alliance Imaging, of Orange, CA, turnedin strong revenue and net income numbers for 1996 (end-December).The company said that its debt restructuring is nearly complete,which will enable Alliance to accelerate its growth plan.
For the year, Alliance posted revenues of $68.5 million, up 18%compared with revenues of $58.1 million in 1995. Net income morethan tripled to $12.8 million, compared with $4.1 million theyear before. While last year's net income numbers were helpedby a $6.3 million one-time gain, Alliance's income before extraordinarygains was $6.5 million for 1996, still a big jump from the previousyear.
Alliance exceeded its goals in 1996, according to Richard Zehner,chairman, president, and CEO. Zehner said that the company's purchaseof new scanners, coupled with several acquisitions of smallerimaging providers, helped it generate a big increase in the numberof scans it performed last year.
In other Alliance news, the company continued its scanner purchaseprogram this month, taking delivery of four new 1-tesla MRI scannersmanufactured by GE Medical Systems in an order valued at $7 million.Alliance plans to take delivery of three more GE scanners andthree Siemens magnets in the second quarter, the company said.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
